Stryker Corporation stock is up 7.05% since 30 days ago. The next earnings date is Jan 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75.56% of the previous 44 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 34% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
20 Nov 16:17 | 19 Jan, 2024 | 290.00 | 406 | ||
20 Nov 18:26 | 15 Mar, 2024 | 290.00 | 366 | ||
20 Nov 19:38 | 15 Dec, 2023 | 290.00 | 1035 | ||
20 Nov 19:40 | 15 Dec, 2023 | 290.00 | 1035 | ||
20 Nov 19:40 | 15 Dec, 2023 | 290.00 | 1035 | ||
22 Nov 14:30 | 15 Dec, 2023 | 270.00 | 908 | ||
30 Nov 16:00 | 15 Mar, 2024 | 300.00 | 104 | ||
30 Nov 16:58 | 19 Jan, 2024 | 300.00 | 2159 | ||
01 Dec 15:56 | 15 Mar, 2024 | 290.00 | 401 | ||
01 Dec 17:47 | 19 Jan, 2024 | 300.00 | 2234 |
Stryker Corporation operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Medsurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products. The Orthopsurgery segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.